Business · 26/06/2025
FDA Classifies Cream for X-Ray Attenuation into Class II Special Controls
The FDA has classified the cream for x-ray attenuation into Class II special controls, aiming to provide a reasonable assurance of safety and effectiveness while reducing regulatory burdens and enhancing patients' access to innovative devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →